Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Raül Pérez‐Ollé
Observed names:
R Perez-Olle,
R. Perez-Olle,
Raul Perez-Olle,
Raul Perez‐Olle,
Raül Pérez-Ollé
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Columbia University Irving Medical Center,
NYU Langone Health,
Lexicon Pharmaceuticals (United States),
MacroGenics (United States),
New York University,
Columbia University
show all 7
ORCID:
0000-0001-9313-3694
Observed ORCID:
0000-0001-9313-3694
OpenAlex ID:
A5080901749
The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway
2006
·
Hui-Jye Chen
, Chung-Ming Lin
, et al.
·
Genes & Development
·
190
PDF
Mutations in the neurofilament light gene linked to Charcot‐Marie‐Tooth disease cause defects in transport
2005
·
Raül Pérez‐Ollé
, Miguel A. López‐Toledano
, et al.
·
Journal of Neurochemistry
·
133
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
2022
·
Hope S. Rugo
, Seock-Ah Im
, et al.
·
Journal of Clinical Oncology
·
87
PDF
Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation
2002
·
Raul Perez-Olle
, Conrad L. Leung
, et al.
·
Journal of Cell Science
·
86
Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models
2004
·
R. Perez-Olle
·
Human Molecular Genetics
·
85
Development of Inhibitors of the IGF-IR/PI3K/Akt/mTOR Pathway
2010
·
Mary L. Hixon
, Luisa Paccagnella
, et al.
·
Reviews on Recent Clinical Trials
·
42
TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World
2019
·
Jonathan Strosberg
, Vijay N. Joish
, et al.
·
The Oncologist
·
21
PDF
The G336S Variant in the Human Neurofilament-M Gene Does Not Affect Its Assembly or Distribution: Importance of the Functional Analysis of Neurofilament Variants
2004
·
Raul Perez-Olle
, Miguel A. Lopez-Toledano
, et al.
·
Journal of Neuropathology & Experimental Neurology
·
18
Autologous Cell Immunotherapy (IGV-001) with IGF-1R Antisense Oligonucleotide in Newly Diagnosed Glioblastoma Patients
2023
·
Ian Y Lee
, Simon Hanft
, et al.
·
Future Oncology
·
15
Direct costs of carcinoid syndrome diarrhea among adults in the United States
2019
·
Arvind Dasari
, Vijay N Joish
, et al.
·
World Journal of Gastroenterology
·
8
PDF
Is a novel I214M substitution in the NEFL gene a cause of Charcot‐Marie‐Tooth disease? Functional analysis using cell culture models
2006
·
Dagmara Kabzińska
, Raul Perez‐Olle
, et al.
·
Journal of the Peripheral Nervous System
·
8
An AC-repeat adjacent to mouse Cdkn2B allows the detection of specific allelic losses in the p15 INK4b and p16 INK4a tumor suppressor genes
1998
·
Marcos Malumbres
, Ignacio Pérez de Castro
, et al.
·
Mammalian Genome
·
8
Burden of Carcinoid Heart Disease in Patients With Carcinoid Syndrome Initiating Somatostatin Analogues
2019
·
Vijay N. Joish
, Raul Perez-Olle
, et al.
·
Clinical Therapeutics
·
5
Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy
2023
·
Carrie E. Andrews
, Jenny Zilberberg
, et al.
·
Journal of Neuro-Oncology
·
4
PDF
Work productivity burden and indirect costs associated with carcinoid syndrome diarrhea
2019
·
Arvind Dasari
, Vijay N. Joish
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
4
Tips-18 Trial in Progress: a Randomized, Multicenter, Double-blind, Placebo-controlled, Phase 2b Study to Assess the Safety and Efficacy of Igv-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (imv-001) Targeting Igf-1r, in Newly Diagnosed Patients With Glioblastoma
2023
·
Raul Perez-Olle
, Madhavi Diwanji
, et al.
·
Neuro-Oncology Advances
·
1
PDF
Pcn113 Direct and Indirect Costs Associated With Carcinoid Syndrome Diarrhea
2019
·
A. Dasari
, V. Joish
, et al.
·
Value in Health
·
1
Neurobiological pathways underlying brain tumor progression: basis for oncogenicity and opportunities for immunotherapeutic intervention
2026
·
Carrie E. Andrews
, Jenny Zilberberg
, et al.
·
Frontiers in Oncology
PDF
Ctim-14. Early Safety Data From a Randomized, Multicenter, Double-blind, Phase 2b Study of Igv-001, an Autologous Cell Immunotherapy, Versus Placebo, in Newly Diagnosed Glioblastoma (ndgbm)
2024
·
J Bradley Elder
, Simon Hanft
, et al.
·
Neuro-Oncology
PDF
Ctim-11. Long-term Survivors From a Phase 1b Study of Igv-001 in Patients With Newly Diagnosed Glioblastoma
2024
·
Raul Perez-Olle
, Greg K Pennock
, et al.
·
Neuro-Oncology
PDF
P12.09.a Early Safety Data From a Randomized, Multicenter, Double-blind, Phase 2b Study of Igv-001, an Autologous Cell Immunotherapy, Versus Placebo, in Newly Diagnosed Glioblastoma
2024
·
S Hanft
, B Elder
, et al.
·
Neuro-Oncology
PDF
Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy
2024
·
Carrie E. Andrews
, Jenny Zilberberg
, et al.
·
Journal of Neuro-Oncology
PDF
Rtid-08. a Randomized, Multicenter, Double-blind, Phase 2b Study of Igv-001, an Autologous Cell Immunotherapy With Antisense Oligo Imv-001 Targeting Igf-1r, Vs Placebo, in Newly Diagnosed Glioblastoma Patients
2023
·
Ian Lee
, Kevin Judy
, et al.
·
Neuro-Oncology
PDF
Ctim-17. Additional Results From a Phase 1b Study of Igv-001 in Patients With Newly Diagnosed Glioblastoma
2023
·
Raul Perez-Olle
, Gregory Pennock
, et al.
·
Neuro-Oncology
PDF
Burden of carcinoid heart disease in patients initiating treatment for carcinoid syndrome.
2019
·
Vijay N Joish
, Raul Perez-Olle
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
26
Citation count:
716
H-index:
9
I10-index:
9
Year
Topic
Type
